References
- American Cancer Society: 1975 cancer facts and figures. New York: American Cancer Society, 1974
- Vana J. Epidemiology. In: Helm F, ed. Cancer dermatology. Philadelphia: Lea & Febiger, 1979:5
- Findlay GM. Ultraviolet light and skin cancer. Lancet 1928;2:1070–3
- Roffo AH. Cancer et soleil: carcinomes et sarcomas provoquees par l'action due soleil in toto. Bull Cancer (Paris) 1934;23:590–616
- Blum HF. Carcinogenesis by ultraviolet light. Princeton, NJ: Princeton University Press, 1959
- Winkelmann RK, Zollman PE, Baldes EJ. Squamous cell carcinoma produced by ultraviolet light in hairless mice. J Invest Dermatol 1963;40:217–24
- Freeman RG, Hudson HT, Carnes R. Ultraviolet wavelength factors in solar radiation and skin cancer. Int J Dermatol 1970;9:232–5
- Urbach F. Geographic distribution of skin cancer. J Surg Oncol 1971;3:219–34
- Ozone: worldwide, many-faceted problem. Science News 1980 Jan 5;117:5–6
- Knox JM, Rossman RE, Freeman RA. Environment and skin cancer. In: Tumors of the skin. Chicago: Year Book Medical Publishers, 1964:15–21
- Norins AL. Free radical formation in the skin following exposure to ultraviolet light. J Invest Dermatol 1962;39:445–8
- Gilchrest BA, Blog FB, Szabo G. Effects of aging and chronic sun exposure on melanocytes in human skin. J Invest Dermatol 1979;73:141–3
- Gellin GA, Kopf AW, Garfinkel L. Malignant melanoma: a controlled study of possibly associated factors. Arch Dermatol 1969;99:43–8
- Urbach F, Rose DB, Bonnem M. Genetic and environmental interactions in skin carcinogenesis. In: Environment and cancer—1971. Baltimore: Williams & Wilkins, 1972:355
- Yeh S. Relative incidence of skin cancer in Chinese in Taiwan: with special reference to arsenical cancer. NCI Monogr 1963;10:81–107
- Guthrie FE, McCants CB, Small HG. Arsenic content of commercial tobacco 1917–1958. Tobacco Science 1959;3:62–4
- Oh MG, Holder BB, Gordon HL. Respiratory cancer and occupational exposure to arsenic. Arch Environ Health 1974;29:250–6
- Dobson RL, Pinto YS. Arsenical carcinogenesis. In: Montagna W, Dobson RL, eds. Advances in biology of skin. Vol 7. Elmsford, NY: Pergamon Press, 1966, 1966:237
- Petres J, Berger A. Zum Einfluss anorganischen Arsens auf die DNS-Synthese menschlicher Lymphocglen in vitro. Arch Dermatol Forsch 1972;242:343–52
- Rossner P, Cinatl J, Bencko Y. Effect of sodium arsenate on cell cultures. Cesk Hyg 1972;17:58–63
- Burgdorf W, Kurvink K, Carvenka J. Elevated sister chromatid exchange rate in lymphocytes of subjects treated with arsenic. Hum Genet 1979;36:69–72
- Cleaver JE. DNA damage and repair in light-sensitive human skin disease. J Invest Dermatol 1970;54:181–95
- Halley DJ, Keijzer W, Jaspers NG, et al. Prenatal diagnosis of xeroderma pigmentosum (group C) using assays of unscheduled DNA synthesis and postreplication repair. Clin Genet 1979 Sep; 16:137–46
- Clark WH Jr, Reimer RR, Greene M, et al. Origin of familial malignant melanomas from heritable melanocytic lesions: “the B-K mole syndrome.” Arch Dermatol 1978; 114:732–8
- Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970;172:902–8
- Kopf AW, Bart RS, Schrager D, et al. Curettage-electrodesiccation treatment of basal cell carcinomas. Arch Dermatol 1977;113:439–43
- Bart RS, Schrager D, Kopf AW, et al. Scalpel excision of basal cell carcinomas. Arch Dermatol 1978;114:739–42
- Bart RS, Kopf AW, Petratos MA. X-ray therapy of skin cancer: evaluation of a standardized method for treating basal ceil epitheliomas. In: Sixth National Cancer Conference Proceedings. Philadelphia: JB Lippincott, 1970:559–69
- Kopf AW, Bart RS, Rodriquez-Saines BS, et al. Malignant melanoma. New York: Masson Publishing USA, 1979
- Goldsmith HS. Melanoma: an overview. CA 1979;29:194–215
- Clark WH Jr, From L, Bernardino EA, et al. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 1969;29:705–27
- McGovern VJ. The classification of melanoma and its relationship with prognosis. Pathology 1970;7:91
- Clark WH Jr, Goldman LI, Mastrangelo MJ, eds. Human malignant melanoma. New York: Grune & Stratton, 1979
- Veronesi V, Adamus J, Bandiera DC, et al. Inefficacy of immediate node dissection in stage I melanoma of the limbs. N Engl J Med 1977;297:627–30
- McBride CM, Sugarbaker EV, Hickey RC. Prophylactic isolation-perfusion as the primary therapy for invasive malignant melanoma of the limbs. Ann Surg 1975;182:316–24
- Krementz ET, Carter RD, Sutherland CM, et al. Malignant melanoma of the limbs: an evaluation of chemotherapy by regional perfusion. In: Proceedings of the 20th Annual Clinical Conference on Cancer, MD Anderson Hospital and Tumor Institute. 1975:375–400
- Carter SK. Dacarbazine. Int J Dermatol 1976;15:59–61
- Morton DL, Eilber FR, Malmgren RA, et al. Immunological factors which influence response to immunotherapy in malignant melanoma. Surgery 1970;68:158–64
- Roenigk HH, Deodhar SD, Krebs JA, et al. Microcytotoxicity and serum blocking factors in malignant melanoma and halo nevus. Arch Dermatol 1975;111:720–5